Antiviral therapy with direct acting anti-virals in hepatitis C patients.

Antiviral therapy with direct acting anti-virals in hepatitis C patients. - Antiviral therapy with direct acting anti-virals in hepatitis C patients.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000016288

Enrollment

500

Registered

2015-01-20

Start date

2014-12-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic hepatitis C

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Chronic hepatitis C 2. Hepatitis C patients treated with direct acting antivirals 3. 20 years old and over 4. Written informed consent for participation in this study is obtained

Exclusion criteria

Exclusion criteria: without abilty to understand informed consent

Design outcomes

Primary

Measure	Time frame
Efficacy and safety of antiviral therapy with direct acting antivirals for chronic hepatitis C.	—

Countries

Japan

Contacts

Public ContactTatsuya Ide

Department of Medicine, Kurume University School of Medicine Division of Gastroenterology

ide@med.kurume-u.ac.jp0942-31-7561

Outcome results